National Health Investors, Inc. (NHI) Stock Rating Reaffirmed by KeyCorp

National Health Investors, Inc. (NYSE:NHI)‘s stock had its “hold” rating reaffirmed by stock analysts at KeyCorp in a note issued to investors on Sunday.

A number of other research analysts also recently commented on NHI. BidaskClub raised shares of National Health Investors from a “sell” rating to a “hold” rating in a research report on Thursday, August 17th. Zacks Investment Research raised shares of National Health Investors from a “sell” rating to a “hold” rating in a research report on Wednesday, August 9th. Finally, Mizuho reaffirmed a “neutral” rating on shares of National Health Investors in a research report on Wednesday, June 28th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and two have issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus target price of $80.50.

Shares of National Health Investors (NHI) opened at 79.99 on Friday. The firm has a market cap of $3.28 billion, a price-to-earnings ratio of 20.54 and a beta of 0.56. National Health Investors has a 12 month low of $66.31 and a 12 month high of $81.29. The company’s 50-day moving average is $78.56 and its 200-day moving average is $75.95.

National Health Investors (NYSE:NHI) last released its quarterly earnings results on Wednesday, August 9th. The real estate investment trust reported $0.93 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.29 by ($0.36). National Health Investors had a net margin of 59.24% and a return on equity of 12.56%. The firm had revenue of $69.84 million for the quarter, compared to analyst estimates of $67.68 million. During the same quarter in the prior year, the firm earned $1.22 EPS. The firm’s revenue was up 14.1% compared to the same quarter last year. On average, equities research analysts forecast that National Health Investors will post $3.85 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “National Health Investors, Inc. (NHI) Stock Rating Reaffirmed by KeyCorp” was first published by Chaffey Breeze and is the property of of Chaffey Breeze. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of US & international trademark and copyright laws. The legal version of this piece of content can be viewed at https://www.chaffeybreeze.com/2017/09/17/national-health-investors-inc-nhi-stock-rating-reaffirmed-by-keycorp.html.

In related news, insider Kevin Carlton Pascoe sold 2,000 shares of the business’s stock in a transaction that occurred on Thursday, August 24th. The shares were sold at an average price of $79.80, for a total transaction of $159,600.00. Following the transaction, the insider now directly owns 21,228 shares of the company’s stock, valued at $1,693,994.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 5.19% of the company’s stock.

A number of institutional investors and hedge funds have recently made changes to their positions in NHI. BlackRock Inc. grew its position in National Health Investors by 6,473.4% during the first quarter. BlackRock Inc. now owns 3,328,567 shares of the real estate investment trust’s stock valued at $241,753,000 after purchasing an additional 3,277,930 shares in the last quarter. Vanguard Group Inc. grew its position in National Health Investors by 3.3% during the first quarter. Vanguard Group Inc. now owns 6,219,436 shares of the real estate investment trust’s stock valued at $451,717,000 after purchasing an additional 201,133 shares in the last quarter. Nuveen Asset Management LLC purchased a new position in National Health Investors during the first quarter valued at approximately $11,559,000. MARSHALL WACE ASIA Ltd purchased a new position in National Health Investors during the first quarter valued at approximately $6,794,000. Finally, Marshall Wace North America L.P. purchased a new position in National Health Investors during the first quarter valued at approximately $6,794,000. 70.58% of the stock is currently owned by hedge funds and other institutional investors.

National Health Investors Company Profile

National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.

Analyst Recommendations for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply